Ironwood Pharmaceuticals (IRWD) Accumulated Expenses (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Accumulated Expenses of $4.7 million for Q1 2026, up 6.51% sequentially from $4.4 million in Q4 2025, and down 61.67% YoY from $12.3 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Accumulated Expenses (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Accumulated Expenses for 17 years, with the latest figure at $4.7 million in Q1 2026.
- Quarterly Accumulated Expenses fell 61.67% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 61.67% YoY) and the FY2025 annual result came in at $4.4 million, down 69.5% from the prior year.
- Accumulated Expenses rose to $4.7 million in Q1 2026 per IRWD's latest filing, from $4.4 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $44.3 million in Q4 2023 and troughed at $188000.0 in Q4 2022.
- A 5-year average of $14.1 million and a median of $12.3 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses tumbled 98.87% in 2022, then jumped 23439.36% in 2023.
- Over 5 years, Accumulated Expenses stood at $188000.0 in 2022, then surged by 23439.36% to $44.3 million in 2023, then sank by 67.13% to $14.5 million in 2024, then tumbled by 69.5% to $4.4 million in 2025, then gained by 6.51% to $4.7 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $4.7 million, $4.4 million, and $7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.53 Mn |
| Mar 31, 2026 | 4.73 Mn |
| Dec 31, 2025 | 4.44 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 24.03 Mn |
| Mar 31, 2025 | 12.33 Mn |
| Dec 31, 2024 | 14.55 Mn |
| Sep 30, 2024 | 33.57 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 12.30 Mn |
| Dec 31, 2023 | 44.25 Mn |
| Sep 30, 2023 | 8.61 Mn |
| Jun 30, 2023 | 31.99 Mn |
| Mar 31, 2023 | 9.40 Mn |
| Dec 31, 2022 | 188,000.00 |
| Sep 30, 2022 | 12.27 Mn |
| Jun 30, 2022 | 13.43 Mn |
| Mar 31, 2022 | 2.11 Mn |
| Dec 31, 2021 | 16.65 Mn |
| Sep 30, 2021 | 2.11 Mn |